Literature DB >> 3028127

Cytomegalovirus infection and bronchopulmonary dysplasia in premature infants.

M H Sawyer, D K Edwards, S A Spector.   

Abstract

During a five-year period, 32 preterm infants weighing less than 2000 g were diagnosed as having postnatally acquired cytomegalovirus (CMV) infection in a neonatal intensive care unit. These CMV-infected infants were matched with 32 uninfected controls for gestational age, birth weight, and birth date; the two groups did not differ in Apgar scores or the incidence of respiratory distress syndrome and patent ductus arteriosus. Roentgenographic evidence of bronchopulmonary dysplasia (BPD) developed in 24 (75%) of 32 CMV-infected infants, an incidence significantly greater than that observed in control infants (12/32; 38%). Infants with acquired CMV infection required more respiratory support and longer hospitalization than uninfected controls. This association between acquired CMV infection in premature infants and the development of chronic lung disease provides further evidence that vigorous efforts to prevent CMV infection in hospitalized neonates is warranted.

Entities:  

Mesh:

Year:  1987        PMID: 3028127     DOI: 10.1001/archpedi.1987.04460030081030

Source DB:  PubMed          Journal:  Am J Dis Child        ISSN: 0002-922X


  11 in total

1.  Symptomatic Postnatal Cytomegalovirus Testing among Very Low-Birth-Weight Infants: Indications and Outcomes.

Authors:  Sagori Mukhopadhyay; Sarah A Meyer; Sallie R Permar; Karen M Puopolo
Journal:  Am J Perinatol       Date:  2016-04-08       Impact factor: 1.862

2.  Hyperoxia potentiates Ureaplasma urealyticum pneumonia in newborn mice.

Authors:  D T Crouse; G H Cassell; K B Waites; J M Foster; G Cassady
Journal:  Infect Immun       Date:  1990-11       Impact factor: 3.441

3.  Prenatal administration of the cytochrome P4501A inducer, Β-naphthoflavone (BNF), attenuates hyperoxic lung injury in newborn mice: implications for bronchopulmonary dysplasia (BPD) in premature infants.

Authors:  Xanthi I Couroucli; Yan-hong Wei Liang; Weiwu Jiang; Lihua Wang; Roberto Barrios; Peiying Yang; Bhagavatula Moorthy
Journal:  Toxicol Appl Pharmacol       Date:  2011-06-26       Impact factor: 4.219

4.  Alveolar Macrophages Are a Prominent but Nonessential Target for Murine Cytomegalovirus Infecting the Lungs.

Authors:  Helen E Farrell; Clara Lawler; Martha T Oliveira; Nick Davis-Poynter; Philip G Stevenson
Journal:  J Virol       Date:  2015-12-30       Impact factor: 5.103

5.  Impaired surfactant production by alveolar epithelial cells in a SCID-hu lung mouse model of congenital human cytomegalovirus infection.

Authors:  Ekaterina Maidji; Galina Kosikova; Pheroze Joshi; Cheryl A Stoddart
Journal:  J Virol       Date:  2012-09-12       Impact factor: 5.103

6.  Association of Adverse Hearing, Growth, and Discharge Age Outcomes With Postnatal Cytomegalovirus Infection in Infants With Very Low Birth Weight.

Authors:  Kristin E D Weimer; Matthew S Kelly; Sallie R Permar; Reese H Clark; Rachel G Greenberg
Journal:  JAMA Pediatr       Date:  2020-02-01       Impact factor: 16.193

Review 7.  Predictors of bronchopulmonary dysplasia.

Authors:  Andrea Trembath; Matthew M Laughon
Journal:  Clin Perinatol       Date:  2012-09       Impact factor: 3.430

Review 8.  Human Breast Milk-acquired Cytomegalovirus Infection: Certainties, Doubts and Perspectives.

Authors:  Flaminia Bardanzellu; Vassilios Fanos; Alessandra Reali
Journal:  Curr Pediatr Rev       Date:  2019

9.  Postmortem diagnosis of cytomegalovirus and accompanying other infection agents by real-time PCR in cases of sudden unexpected death in infancy (SUDI).

Authors:  Gulhan Yagmur; Nihan Ziyade; Neval Elgormus; Taner Das; M Feyzi Sahin; Muzaffer Yildirim; Ayse Ozgun; Arzu Akcay; Ferah Karayel; Sermet Koc
Journal:  J Forensic Leg Med       Date:  2015-11-23       Impact factor: 1.614

10.  Postnatal Cytomegalovirus Infection and the Risk for Bronchopulmonary Dysplasia.

Authors:  Matthew S Kelly; Daniel K Benjamin; Karen M Puopolo; Matthew M Laughon; Reese H Clark; Sagori Mukhopadhyay; Daniel K Benjamin; P Brian Smith; Sallie R Permar
Journal:  JAMA Pediatr       Date:  2015-12-07       Impact factor: 26.796

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.